Strategies for engineering human chromosomes with therapeutic potential

Journal of Gene Medicine

Volumn 4, Issue 1, 2002, Pages 5-13

  Saffery, Richard ^a   Choo, K H Andy ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Chromosome engineering; Gene therapy; Human artificial chromosomes; Human engineered chromosomes

Indexed keywords

CENTROMERE PROTEIN B; COMPLEMENTARY DNA; DNA; EXTRACHROMOSOMAL DNA; IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 2; NUCLEAR PROTEIN; SATELLITE DNA; UNCLASSIFIED DRUG; DNA FRAGMENT;

ARTIFICIAL CHROMOSOME; CENTROMERE; CHROMOSOME 1P; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CYTOGENETICS; DNA MODIFICATION; EX VIVO STUDY; GENE DISRUPTION; GENE EXPRESSION; GENETIC ENGINEERING; GENETIC MANIPULATION; HOST CELL; HUMAN; IMMUNOGENICITY; METHODOLOGY; MICROCHROMOSOME; MOLECULAR CLONING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; Y CHROMOSOME; GENE THERAPY; GENE VECTOR;

CHROMOSOMES, ARTIFICIAL, HUMAN; DNA FRAGMENTATION; DNA, SATELLITE; GENE THERAPY; GENETIC VECTORS; HUMANS;

EID: 0036369660     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.236     Document Type: Review

References (53)

1. Cavazzana-Calvo M, Hacein-Bey S, Yates F, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-672.
2. Kay MA, Glorioso JC, Naldini L. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genet 2000; 24: 257-261.
3. Brown WR. Mammalian artificial chromosomes. Curr Opin Genet Dev 1992; 2: 479-486.
4. Huxley C. Mammalian artificial chromosomes: a new tool for gene therapy. Gene Ther 1994; 1: 7-12.
5. Harrington JJ, Van Bokkelen G, Mays RW, et al. Formation of de novo centromeres and construction of first-generation human artificial microchromosomes. Nature Genet 1997; 15: 345-355.
6. Ikeno M, Grimes B, Nakano M, et al. Construction of YAC-based mammalian artificial chromosomes. Nature Biotechnol 1998; 16: 431-439.
7. Masumoto H, Ikeno M, Nakano M, et al. Assay of centromere function using a human artificial chromosome. Chromosoma 1998; 107: 406-416.
8. Ebersole TA, Ross A, Clark E, et al. Mammalian artificial chromosome formation from circular alphoid input DNA does not require telomere repeats. Hum Mol Genet 2000; 9: 1623-1631.
9. Mejia JE, Willmott A, Levy E, et al. Functional complementation of a genetic deficiency with human artificial chromosomes. Am J Hum Genet 2001; 69: 315-326.
10. Mejia JE, Larin Z. The assembly of large BACs by in vivo recombination. Genomics 2000; 70: 165-170.
11. Henning KA, Novotny FA, Compton ST, et al. Human artificial chromosomes generated by modification of a yeast artificial chromosome containing both human alpha satellite and single-copy DNA sequences. Proc Natl Acad Sci USA 1999; 96: 592-597.
12. Heller R, Brown KE, Burgtorf C, Brown WR. Mini-chromosomes derived from the human Y chromosome by telomere directed chromosome breakage. Proc Natl Acad Sci USA 1996; 93: 7125-7130.
13. Kereso J, Praznovsky T, Cserpan I, et al. De novo chromosome formations by large-scale amplification of the centromeric region of mouse chromosomes. Chromosome Res 1996; 4: 226-239.
14. Voet T, Vermeesch J, Carens A, et al. Efficient male and female germline transmission of a human chromosomal vector in mice. Genome Res 2001; 11: 124-136.
15. Kuroiwa Y, Tomizuka K, Shinohara T, et al. Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts. Nature Biotechnol 2000; 18: 1086-1090.
16. Saffery R, Wong LH, Irvine DV, et al. Construction of neocentromere-based human minichromosomes by telomere-associated chromosomal truncation. Proc Natt Acad Sci USA 2001; 98: 5705-5710.
17. Challita PM, Kohn DB. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc Natl Acad Sci USA 1994; 91: 2567-2571.
18. Bestor TH. Gene silencing as a threat to the success of gene therapy. J Clin Invest 2000; 105: 409-411.
19. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1990; 1: 111-123.
20. Piedra PA, Poveda GA, Ramsey B, et al. incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics 1998; 101: 1013-1019.
21. Franklin RM, Quick MM, Haase G. Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequences. Gene Ther 1999; 6: 1360-1367.
22. Grimes BR, Schindelhauer D, McGill NI, et al. Stable gene expression from a mammalian artificial chromosome. EMBO rep 2001; 2: 910-914.
23. Willard HF. Genomics and gene therapy. Artificial chromosomes coming to life. Science 2000; 290: 1308-1309.
24. Brown WRA, Mee PJ, Shen MH. Artificial chromosomes: ideal vectors? Trends Biotechnol 2000; 18: 218-223.
25. de Jong G, Telenius AH, Telenius H, et al. Mammalian artificial chromosome pilot production facility: large-scale isolation of functional satellite DNA-based artificial chromosomes. Cytometry 1999; 35: 129-133.
26. Telenius H, Szeles A, Kereso J, et al. Stability of a functional murine satellite DNA-based artificial chromosome across mammalian species. Chromosome Res 1999; 7: 3-7.
27. Co DO, Borowski AH, Leung JD, et al. Generation of transgenic mice and germline transmission of a mammalian artificial chromosome introduced into embryos by pronuclear micro-injection. Chromosome Res 2000; 8: 183-191.
28. Csonka E, Cserpan I, Fodor K, et al. Novel generation of human satellite DNA-based artificial chromosomes in mammalian cells. J Cell Sci 2000; 113: 3207-3216.
29. Raimondi E, Balzaretti M, Moralli D, et al. Gene targeting to the centromeric DNA of a human minichromosome. Hum Gene Ther 1996; 7: 1103-1109.
30. Dieken ES, Epner EM, Fiering S, et al. Efficient modification of human chromosomal alleles using recombination-proficient chicken/human microcell hybrids. Nature Genet 1996; 12: 174-182.
31. Shinohara T, Tomizuka K, Takehara S, et al. Stability of transferred human chromosome fragments in cultured cells and in mice. Chromosome Res 2000; 8: 713-725.
32. Parry GC, Erlich JH, Carmeliet P, et al. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998; 101: 560-569.
33. Guiducci C, Ascenzioni F, Auriche C, et al. Use of a human minichromosome as a cloning and expression vector for mammalian cells. Hum Mol Genet 1999; 8: 1417-1424.
34. Shen MH, Yang JW, Yang J, et al. The accuracy of segregation of human mini-chromosomes varies in different vertebrate cell lines, correlates with the extent of centromere formation and provides evidence for a trans-acting centromere function. Chromosoma 2001; 109: 524-535.
35. Taylor SS, Larin Z, Tyler-Smith C. Analysis of extrachromosomal structures containing human centromeric alphoid satellite DNA sequences in mouse cells. Chromosoma 1996; 105: 70-81.
36. Auriche C, Donini P, Ascenzioni F. Molecular and cytological analysis of a 5.5 Mb minichromosome. EMBO Rep 2001; 2: 102-107.
37. R marker into a 2- to 3-Mb human minichromosome and transfer between cells. Cytogenet Cell Genet 1999; 86: 194-203.
38. Farr CJ, Stevanovic M, Thomson EJ, et al. Telomere-associated chromosome fragmentation: applications in genome manipulation and analysis. Nature Genet 1992; 2: 275-282.
39. Moyzis RK, Buckingham JM, Cram LS, et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622-6626.
40. Farr CJ, Bayne RA, Kipling D, et al. Generation of a human X-derived minichromosome using telomere-associated chromosome fragmentation. EMBO J 1995; 14: 5444-5454.
41. Mills W, Critcher R, Lee C, Farr CJ. Generation of an approximately 2.4 Mb human X centromere-based minichromosome by targeted telomere-associated chromosome fragmentation in DT40. Hum Mol Genet 1999; 8: 751-761.
42. Shen MH, Yang J, Loupart ML, et al. Human mini-chromosomes in mouse embryonal stem cells. Hum Mol Genet 1997; 6: 1375-1382.
43. Loupart ML, Shen MH, Smith A. Differential stability of a human mini-chromosome in mouse cell lines. Chromosoma 1998; 107 255-259.
44. Yang JW, Pendron C, Yang J, et al. Human mini-chromosomes with minimal centromeres. Hum Mol Genet 2000; 9 1891-1902.
45. Choo KHA. Domain organisation at the centromere. Dev Cell 2001; 1: 165-177.
46. Choo KHA. Centromerization. Trends Cell Biol 2000; 10: 182-188.
47. Saffery R, Irvine DV, Griffiths B, et al. Human centromeres and neocentromeres show identical distribution patterns of > 20 functionally important kinetochore-associated proteins. Hum Mol Genet 2000; 9: 175-185.
48. du Sart D, Cancilla MR, Earle E, et al. A functional neocentromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nature Genet 1997; 16: 144-153.
49. Barry AE, Howman EV, Cancilla MR, et al. Sequence analysis of an 80 kb human neocentromere. Hum Mol Genet 1999; 8 217-227.
50. Barry AE, Bateman M, Howman EV, et al. The 10q25 neocentromere and its inactive progenitor have identical primary nucleotide sequence: further evidence for epigenetic modification. Genome Res 2000; 10: 832-838.
51. Henning KA, Friedberg EC. Techniques and applications of microcell-mediated chromosome transfer to mammalian cells. In Methods in Molecular Genetics, vol 1. Academic Press: London, 1993; 134-150.
52. Munsie MJ, Michalska AE, O'Brien CM, et al. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr Biol 2000; 10: 989-992.
53. Kondo T, Raff M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 2000; 289: 1754-1757.